• Article highlight
  • Article tables
  • Article images

Article History

Received : 23-01-2023

Accepted : 23-03-2023



Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 840

PDF Downloaded: 191


Get Permission Aswar, Murarkar, and Baviskar: Epidemiological distribution and drug utilization study in patients with respiratory tract diseases at district general hospital Amravati, Maharashtra, India


Introduction

Respiratory tract disease involves diseases which affects the lungs and other parts of the respiratory system. This disease may be caused by infection, by smoking tobacco, or by breathing in second hand tobacco smoke, radon, asbestos, or other forms of air pollution. Respiratory diseases include asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, pneumonia, tuberculosis and lung cancer. They are also known as lung disorder and pulmonary disease.

Respiratory diseases impose an immense worldwide health burden. Five of these diseases are among most common causes of severe illness and death worldwide. 1

COPD- Chronic obstructive pulmonary disease (COPD), a common preventable and treatable disease, is characterized by persistent airflow limitation that is usually progressive and that is caused by an enhanced chronic inflammatory response in the airways and the lung to noxious particles or gases. 2

Asthma- Asthma is defined as a chronic inflammatory disease of the airways. The chronic inflammation is associated with airway hyperresponsiveness (an exaggerated airway-narrowing response to specific triggers such as viruses, allergens and exercise) that leads to recurrent episodes of wheezing, breathlessness, chest tightness and/or coughing that can vary over time and in intensity. 3

TB- It is a chronic disease caused by the bacillus Mycobacterium tuberculosis and spreads from person to person through air. TB usually affects the lungs but it can also affect other parts of the body, such as brain, intestines, kidneys, or the spine. Symptoms of TB depend on where in the body the TB bacteria are growing. 4

LRTI- Lower respiratory tract infection (LRTI) is a broad terminology which includes acute bronchitis, pneumonia, acute exacerbations of chronic obstructive pulmonary disease/chronic bronchitis (AECB), and acute exacerbation of bronchiectasis. 5

RAD- Reactive airway disease (RAD) is similar to asthma. RAD occurs when your bronchial tubes, which bring air into your lungs, overreact to an irritant, swell, and cause breathing problems. 6

Respiratory diseases account for more than 10% of all disability-adjusted life-years (DALYs), a metric that estimates the amount of active and productive life lost due to a condition. 7 They are second only to cardiovascular diseases (including stroke). 8 Altogether, more than 1 billion people suffer from either acute or chronic respiratory conditions. The stark reality is that, each year, 4 million people die prematurely from chronic respiratory disease. 9 Infants and young children are particularly susceptible. A total of 9 million children under 5 years old die annually, and pneumonia is the world’s leading killer of these children. 1

Epidemiology is study of use and effects of drugs in a large number of populations. Epidemiological distribution involves gathering and analysis of information in order to identify possible causation and related factors that can be applied in clinical practise to group of people and also individual undergoing treatment. It examines the relationship between drug exposure and health outcome in a defined population. Drug utilization focuses on the various medical, social, and economic aspects of drug use. Medical consequences include the risks and benefits of drug therapy, whereas social aspects can be related to inappropriate use. Economic issues deal with the cost of drugs and treatment for patients and society. 10

In this study, the in-patient and out-patient department represented an important platform for conducting such studies as patients from all over Amravati district present with a wide range of respiratory diseases and the drug use is quite extensive at District general hospital, Amravati. Therefore, evaluating the epidemiological distribution and the drug usage patterns in this departmental setting has the potential of determining the epidemiology and rationality of drug therapy being given in the particular region to a broader extent.

Materials and Methods

A cross sectional observational study was conducted in both out-patient and in-patient department of District general hospital, Amravati & District T.B. hospital, Amravati for a period of 6 months October-21 to March-22. Patient demographics and drugs prescription data were collected and analysed. Along with this interaction with the patient was also done whenever required. This was an observational study involving all the patients with both genders and all ages who are suffering from Respiratory tract diseases. The patients who were not willing to participate and pregnant women were excluded from the study.

The present study was initiated with an enrolment of patients based on inclusion and exclusion criteria. The patients who were visiting the tertiary care centre were monitored in the study. The patient background information like age, gender and reason for hospital visit were collected. The patient’s diagnosis and prescribed medicines were noted. All the drugs prescribed for the patients were noted and monitored. To achieve the desired outcome Convenience sampling, a non-probability sampling method was used. The collected data was entered in Microsoft excel and analysed for frequency and percentages, the results were demonstrated in the forms of table and graphs. The convenience sampling method is the most applicable and widely used method in clinical research. 11

Figure 1

Patients were enrolled into study by considering the following criteria

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/4393d34e-639a-4d33-bdbb-4e7e7a604f71image1.png

Results

In this project, we observed the epidemiological distribution and how the drugs are utilized by the physician. Epidemiological distribution and drug utilization study was done on the basis of prospective and retrospective study, age, gender, region patient belonging to, social history, clinical features, given treatment, Name of drug (Antibiotics, Proton pump inhibitor and other antacids, Multivitamins, Bronchodilators, Antihistaminic, NSAIDs, Antipyretic, Nebulization) and Fixed dose combination, etc.

Table 1

Showing the distribution of various types of respiratory tract diseases according to prospective and retrospective study

Type of study

LRTI

TB

COPD

Asthma

RAD

Prospective

23 (12.50%)

36 (19.56%)

14 (7.60%)

11 (5.97%)

4 (2.17%)

Retrospective

33 (17.93%)

23 (12.50%)

21 (11.41%)

16 (8.69%)

3 (1.63%)

Total

56 (30.43%)

59 (32.06%)

35 (19.01%)

27 (14.67%)

7 (3.80%)

Percentage (%)

30.43

32.06

19.01

14.67

3.8

Out of which TB contributes 32.06% of total study including both retrospective and prospective, followed by LRTI, COPD, ASTHMA, RAD which contribute 30.43%, 19.02%, 14.67%, 3.8% respectively.Table 1

Table 2

Showing the distribution of various types of respiratory tract diseases according to age group and gender

Disease

LRTI

TB

COPD

Asthma

RAD

Total

Age Group (Years)

M

F

M

F

M

F

M

F

M

F

M

F

1 month to 10

10

27

0

0

0

0

6

1

1

2

17

30

 10 to 20

0

1

1

1

0

1

0

1

0

0

1

4

20 to 60

10

2

40

10

5

5

11

3

2

0

68

20

Above 60

4

2

3

4

19

5

3

2

2

0

31

13

In the current study, a total number of 184 medical records of hospitalized patients with RTD between 2020 and 2021 were reviewed. The majority of patients were males 63.58% and 36.42% were females.

Active smoking remains the main risk factor, but other factors are becoming better known, such as occupational factors, infections and the role of air pollution. Prevalence of COPD varies according to country, age and gender. This disease is also associated with significant comorbidities. The majority of the studies (12.49%) concerned patients above 60 years of age, in particular those aged between 20 to above 60 yrs. Total 19(10.32%) male and 5(2.71%) female was affected with COPD out of total 35(19.01%) patients Female and male are equally affected with COPD in age group of 20-60 years, contributing 5(2.17%) male & 5(2.17%) female out of 35 patients.

Briefly out of 184 patients of RTD 27(14.67%) patient were affected with asthma in which 20(10.86%) were male and 7(3.79%) were female. Among infectious diseases on the surface of the globe Tuberculosis (TB) is a leading cause of mortality and morbidity. The present study describes the distribution of TB at District general hospital, Amravati. It was observed that the highest burden of TB cases has been found in male as compared to female with a ratio of 23.91% and 8.14% respectively out of total 184 patient of RTD. High occurrence of TB was recorded in the age group of 21-60 years (27.16%).

LRTI is most common in paediatric patients (30.43%), especially in the age group ranging from 1 month to 10 years. In this age group female are severely affected as compared to male Our study reveals that the reason why LRTI is most common in paediatric patients is that children’s and infants has weakened or less immune system as compared adults and highly sensitive to respiratory irritants like dust, pollen grains and other environmental factor. The study shows that, the majority of people affected with LRTI was belonging to age group of 20-60 years out of which 11(5.97%) were male and 3(1.63%) were female.

Out of 184 individuals, 7 (3.80%) were affected with to have RAD. Total 5 (2.71%) male and 2(1.08%) female was affected with RAD. Age group of 1 month to 10 years was mostly affected contributing total 1.62% of RT disease. Followed by age group of 10 to 20 & 20 to 60 contributing equally i.e. 1.08%.

Figure 2

Distribution of RTD patient’s according to region patient belonging to, out of 184 patients, majority of the patients were from Amravati region 45 (24.45%) and the least number of patients were from out of Amravati 02 (1.08%).

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/80f73dc2-b82b-4e06-a42e-e75f4bcaddb0/image/ee8bfe66-e45b-4c6d-9463-59034df8a19f-uimage.png

Table 3

Classification based on social history of RTD patients, Majority of Patients with RTD had social history of Alcoholic + Tobacco 108(46.35%), followed by Primary smoker 77(33.04%).

Social History

Patients

Primary smoker (Bidi/cigarette/Hookah)

77(33.04%)

Alcoholic + Tobacco

108(46.35%)

Occupational

12(5.15%)

Past Medical/Medication History

36(15.45%)

Table 4

Showing the prescribing pattern of drugs in respiratory tract diseases.

Parameter

Total number

Total no. of prescriptions

184

Total no. of drug prescribed

923

Average no. of drug per prescription

5.1

Total no. of antibiotics

301

Total no. of FDC drugs

381

There were 301 antibiotics prescribed by a physician in 184 prescriptions contributing about 32.61% of total population enrolled in the study. Fixed dose combinations are the medications with a combination of 2 or more drugs with fixed doses. The physician prescribed 381(41.27%) FDC drugs in total.Table 4

Table 5

Showing the number of FDC drugs prescribed for respiratory tract disease during the study period.

FDC drug

Total number

Amoxicillin + Clavulanic acid

86

Levocetirizine + Montelukast

11

Piperacillin + Tazobactam

40

Etofylline + Theophylline

69

Deriphylline + Dexamethasone

119

HRZE

43

MDR- drugs

13

Table 6

Showing the total number of different classes of drugs prescribed by physician during the study period.

Parameter

LRTI

TB

COPD

Asthma

RAD

Total

Antibiotics

111

62

78

43

7

301

Proton pump inhibitor and other antacids

37

65

13

18

6

139

Multivitamins

37

53

16

15

6

127

Bronchodilators

15

11

18

19

2

65

Antihistaminic

28

18

17

15

11

89

NSAIDs

15

8

11

9

5

48

Antipyretic

14

7

8

10

3

42

Nebulisation

9

11

15

13

3

51

Drugs were prescribed as per indicated symptoms of patients. Our study shows antibiotics (32.61%) are the most prescribed drugs for RTD followed by Proton pump inhibitors (15.05%), multi- vitamins (13.86%) and anti-histaminic (9.64%).

Table 7

Showing the total number ofdifferent dosage forms used during the study period

Dosage form

Total number

Tablets

154 (17%)

Capsules

139 (15%)

Syrups

57 (6%)

Injections

425 (46%)

Nebulisation/Nasal spray

62 (7%)

IV injectables

86 (9%)

Different routes of administration like oral, Intravenous and Nasal sprays were used in the present study. A few rotahalers were also prescribed in some prescriptions. The Intravenous route of administration 425(46%) was more preferred to other routes. It was followed by oral route 154(17%) and Nasal route was the least preferred 62(7%).Table 7

Discussion

A cross-section observational study was conducted among out-patients as well as in-patients those who visit District general hospital Amravati and Government GG Rathi TB hospital, Amravati for the management of Respiratory tract diseases. This study was done to study Epidemiological distribution and use of drugs as both play an important role in improving human health and in promoting well-being. In this study, the patients were classified according to age group, 1 month to 10 years included 17 males and 30 females, 10 to 20 years included 1 male and 4 female, 20 to 60 years included 68 males and 20 females, above 60 years included 31 males and 13 females. From the above data, RTD are more prevalent in age group between 20-60 years. When the gender is taken into consideration from the collection 184 cases, males 63.58% and 36.42% were females. From this data, we observed that males are more prone to RTD when compared to females. 56(30.43%) patients were with LRTI, 59(32.06%) with TB, 35(19.01%) with COPD, 27(14.67%) with Asthma and 7(3.8%) with RAD.

Drug prescriptions form a very important point of contact between the doctor and the patients. In total 923 drugs prescribed for 184 patients, among those 301 were antibiotics, and others include histamine blockers, Proton pump inhibitors, multi-vitamins, bronchodilators, NSAIDs, antipyretics and nebulisation. Drugs were prescribed as per indicated symptoms, of patients. Our study shows antibiotics (32.61%) are the most prescribed drugs for RTD followed by Proton pump inhibitors (15.05%), multi- vitamins (13.86%) and anti-histaminic (9.64%) among the 184 cases. Overall prescribing patterns suggested that monotherapy 542 (58.72%) is most frequently used than combination therapy 381 (41.27%).

LRTI patients were diagnosed by chest X-ray and CRP, TB patients were diagnosed by AFB, DST, CBNAAT, Chest X-ray, COPD and Asthma patients were diagnosed by Lung function test, Chest X-ray, CRP and RAD patients were diagnosed by Chest X-ray, CRP. Most of RTD patients in our study had social history of Alcohol consumption, Primary smoker and Tobacco chewer belonging to Amravati region.

The present study is one of few single centre studies related to Respiratory tract diseases in Amravati district. Its findings may improve our insight into the clinical, epidemiological distribution and drug utilization of patients with RTD. These data may reveal important information for program managers and policy makers at regional and national levels to help priority settings, program planning, and resource allocation as well as to determine the most cost-effective treatment and preventive interventions. However, additional studies are required among population with RTD to develop appropriate preventive and therapeutic strategies.

Conclusion

From this study, males were 63.58% and females were 36.42%. We observed that males are more prone to RTD when compared to females. Based on age, RTD are more prevalent in age group between 20-60 years. When prescriptions were screened thoroughly, antibiotics were not prescribed in the 67.38% of cases. Most commonly used antibiotic was Amoxicillin clavulanic acid. Most drugs are prescribed by brand names. Prescribing by generic drugs helps the hospital pharmacy to have better inventory control and has to be encouraged with patient counselling for cessation of Alcohol, smoking and tobacco chewing. The findings from this study may provide important missing data on RTD and give precise insights into identification of risk factors that can be modified with simple strategies such as immunizations, parental education, adequate nutrition, environmental sanitation, avoidance of pollution and appropriate counselling. Though there has been lots of work reported on this topic presently, however there are several untouched aspects about co-relation of epidemiological distribution and drug utilization study in patients with Respiratory tract diseases. Keeping this in view, the study was conducted.

Conflict of Interest

The authors declare that they have no conflict of interest.

Source of Funding

None.

Acknowledgement

We express our thanks to Dr. S.S. Khadibadi, Principal, Government college of Pharmacy, Amravati for necessary facilities, helping and motivating us during the project work. We also thank District general Hospital, Amravati for providing patient data and co-operation.

References

1 

H Wang M Naghavi C Allen RM Barber ZA Bhutta A Carter Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015Lancet20153881005315445910.1016/S0140-6736(16)31012-1

2 

H Qureshi A Sharafkhaneh N A Hanania Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implicationsTher Adv Chronic Dis20145521227

3 

A Quirt K J Hildebrand J Mazza F Noya H Kim AsthmaAllergy Asthma Clin Immunol20181425010.1186/s13223-018-0279-0

4 

K Zaman Tuberculosis: A Global Health ProblemJ Health Popul Nutr2010282111310.3329/jhpn.v28i2.4879

5 

A Mahashur Management of lower respiratory tract infection in outpatient settings: Focus on clarithromycinLung India2018352143910.4103/lungindia.lungindia_262_17

6 

LC Douglas KJ Feder RAD: reactive airways disease or really asthma diseasePediatrics20171391e2016062510.1542/peds.2016-0625

7 

Forum of International Respiratory Societies. The Global Impact of Respiratory Disease–Second EditionSheffield, European Respiratory Society2017

8 

Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015Lancet201538810053160358

9 

World Health Organization. (2014). Global status report on noncommunicable diseases (No. WHO/NMH/NVI/15.1). World Health Organization2014https://apps.who.int/iris/bitstream/handle/10665/148114/9789241564854_eng.pdf

10 

B Wettermark M Elseviers AB Almarsdóttir M Andersen R Benko M Bennie Drug Utilization Research: Methods and ApplicationsWiley-Blackwell2016536

11 

M Elfil A Negida Sampling methods in clinical research; an educational reviewEmergency201751 e52



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.